Spyre Therapeutics
SYRE
#4930
Rank
โ‚น119.09 B
Marketcap
โ‚น2,029
Share price
3.16%
Change (1 day)
34.24%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -โ‚น5,936

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น6,137. In 2023 the company made an earnings per share (EPS) of -โ‚น4,176 a decrease over its 2022 EPS that were of -โ‚น2,104.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น5,93642.14%
2023-โ‚น4,17698.46%
2022-โ‚น2,104-1%
2021-โ‚น2,126-34.21%
2020-โ‚น3,231-37.96%
2019-โ‚น5,20815.02%
2018-โ‚น4,52818.33%
2017-โ‚น3,826-18.92%
2016-โ‚น4,719120.2%
2015-โ‚น2,143-33.55%
2014-โ‚น3,225